Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.
Wada M, Yamamoto M, Ryuge S, Nagashima Y, Hayashi N, Maki S, Otani S, Katono K, Takakura A, Yanaihara T, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Masuda N.
Wada M, et al. Among authors: masuda n.
Cancer Chemother Pharmacol. 2012 Apr;69(4):1005-11. doi: 10.1007/s00280-011-1795-5. Epub 2011 Dec 8.
Cancer Chemother Pharmacol. 2012.
PMID: 22160350
Clinical Trial.